Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00906737 · ClinicalTrials.gov registry record · NA

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

A NA study of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT00906737: Completed NA study of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.

NCT00906737 is a NA study of Multiple Sclerosis that has completed, run by Mount Sinai Rehabilitation Hospital. The registered enrollment target is 18 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00906737, a NA study of Multiple Sclerosis, has completed, sponsored by Mount Sinai Rehabilitation Hospital.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused ankle therapy in improving the gait of subjects with MS.

Conditions Studied

Multiple Sclerosis

Interventions

  • DEVICE Ankle-bot
  • OTHER Conventional focused ankle therapy

Study Locations (1)

Connecticut

  • Mandell Center for Multiple Sclerosis at Mount Sinai Rehabilitation Hospital - Hartford

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2009-04
Est. Completion 2012-04
Phase NA
Mount Sinai Rehabilitation Hospital

4 total trials

What the finished NCT00906737 record still lists

NCT00906737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Ankle-bot is the first listed.

NCT00906737 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT00906737 about?

NCT00906737 is a clinical study titled "Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities". This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused...

What is the current status of trial NCT00906737?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2009-04. Estimated completion is 2012-04.

What conditions does trial NCT00906737 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT00906737?

The interventions under investigation include: Ankle-bot (DEVICE), Conventional focused ankle therapy (OTHER).

Who is sponsoring clinical trial NCT00906737?

This trial is sponsored by Mount Sinai Rehabilitation Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00906737 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00906737's enrollment target sits among peer trials

18 279th of 315 higher than 36 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00906737, the US trial registry maintained by the National Library of Medicine. NCT00906737 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.